You are here: Industry Insights > Sanofi

News List

Sanofi to acquire Synthorx for $2.5 B biospectrumasia
December 12, 2019
Sanofi and Synthorx, a clinical-stage biotechnology company focused on prolonging and improving the lives of people suffering from cancer and autoimmune disorders.
Sanofi aims to save €2B through job cuts, smarter buying fiercepharma
December 12, 2019
Like many a corporate rejuvenation plan, CEO Paul Hudson's blueprint for Sanofi includes some hefty cost cutting.
Sanofi to acquire Synthorx for $2.5bn to strengthen immuno-oncology pipeline pharmaceutical-business-review
December 12, 2019
Sanofi has agreed to acquire US-based clinical-stage biotechnology company Synthorx for about $2.5bn in an all-cash deal in a move to strengthen its immuno-oncology (IO) pipeline.
Sanofi and Regeneron to simplify antibody partnership pharmaceutical-technology
December 12, 2019
Sanofi and Regeneron Pharmaceuticals have said the companies may transform their antibody partnership, which involves Kevzara (sarilumab) and Praluent (alirocumab) drugs ...
Sanofi, Regeneron splitting up on Praluent, Kevzara fiercepharma
December 11, 2019
After more than a decade of working together, Sanofi and Regeneron's drug partnership finally turned a profit recently on the back of strong sales of blockbuster Dupixent.
Sanofi agrees to pay $2.5bn for biotech firm Synthorx pharmaceutical-technology
December 10, 2019
French pharmaceutical company Sanofi has agreed to acquire all outstanding shares of biotechnology firm Synthorx for a total consideration of $2.5bn, or $68 per share in cash.
Sanofi, Abbott team up to enhance diabetes management biospectrumasia
September 17, 2019
Collaboration aims to provide a connected device experience for millions of people living with diabetes using insulin
Sanofi evaluates impact and prevention of influenza at ‘Options X’ biospectrumasia
September 05, 2019
Flu which can lead to pneumonia, heart attack and stroke is now preventable through Flublok®, the first recombinant Influenza Vaccine and Fluzone® High-Dose Vaccine (IIV3-HD)
Sanofi Announces New CEO americanpharmaceuticalreview
September 05, 2019
Sanofi has announced Paul Hudson has started his tenure as CEO. The company has offered “best wishes” to Olivier Brandicourt, who is retiring.
Sanofi, Regeneron score win against Amgen patents on PCSK9 med Repatha fiercepharma
September 02, 2019
Sanofi and Regeneron have been battling with PCSK9 rival Amgen over patents on their cholesterol drugs for years, with Amgen at one point blocking sales of the partners’ Praluent. Now, Sanofi and Regeneron have persuaded a judge that certain claims of two

Previous page 1 2 3 4 5 6 7 8 9 10 ... 43 44 Next page